First Time Loading...
A

AFT Pharmaceuticals Ltd
NZX:AFT

Watchlist Manager
AFT Pharmaceuticals Ltd
NZX:AFT
Watchlist
Price: 2.97 NZD -1% Market Closed
Updated: May 7, 2024

AFT Pharmaceuticals Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AFT Pharmaceuticals Ltd
Revenue Peer Comparison

Comparables:
BLT
CBD
RUA
G
GFI

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
A
AFT Pharmaceuticals Ltd
NZX:AFT
Revenue
NZ$174.5m
CAGR 3-Years
18%
CAGR 5-Years
16%
CAGR 10-Years
N/A
BLIS Technologies Ltd
NZX:BLT
Revenue
NZ$10.2m
CAGR 3-Years
-1%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Cannasouth Ltd
NZX:CBD
Revenue
NZ$955.6k
CAGR 3-Years
94%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Rua Bioscience Ltd
NZX:RUA
Revenue
NZ$357.7k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Greenfern Industries Ltd
NZX:GFI
Revenue
NZ$550.9k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is AFT Pharmaceuticals Ltd's Revenue?
Revenue
174.5m NZD

Based on the financial report for Sep 30, 2023, AFT Pharmaceuticals Ltd's Revenue amounts to 174.5m NZD.

What is AFT Pharmaceuticals Ltd's Revenue growth rate?
Revenue CAGR 5Y
16%

Over the last year, the Revenue growth was 24%. The average annual Revenue growth rates for AFT Pharmaceuticals Ltd have been 18% over the past three years , 16% over the past five years .